RxDoctor Payments Data

Xitong Wu, MD

Psychiatry · Houston, TXNPI 1609491984

Payments from drug & device makers

$1,449in general payments, 2019–2025

Across 80 payments — averaging $18.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$439
  • Otsuka America Pharmaceutical, Inc.$272
  • Teva Pharmaceuticals USA, Inc.$152
  • Neurocrine Biosciences, Inc.$149
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$86
  • Vanda Pharmaceuticals Inc.$78
  • plus $272 from 6 others

What the payments were for

  • Food & beverage$1,42999%
  • Education$191%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,449 in reported general payments places this provider in the 70th percentile of 2,238 psychiatry providers in Texas.

See all psychiatry providers in Texas

Medicare billing

Part B allowed, 2024
$13,543
Medicare patients
21
Services billed
136

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine11$46,414
Divalproex Sodium14$1,494
Buspirone Hcl43$848
Oxcarbazepine20$654
Quetiapine Fumarate19$527
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine20$520
Olanzapine16$466
Trazodone Hcl67$464
Mirtazapine29$458
Guanfacine Hcl12$433
Alprazolam34$333
Bupropion XlBupropion Hcl20$332
Risperidone27$278
Duloxetine Hcl14$246
Lithium Carbonate22$228

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$152$46,41411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,238 psychiatry providers in Texas.

Other psychiatry in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →